Lars Petersen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Than half have 10,000 or left put away. What can be done to get americans to save more . Thats our cover story. Retirement in the u. S. Is becoming increasingly selffunded. In 197938 of private employers offer pension. Now its just 13 . The guaranteed retirement benefit is still common for government workers and union members, but private employers are more likely to offer 401 k s, employees put a portion of their pretax salary into taxdeferred accounts. Employers can match those contributions, although they dont have to. Unlike pensions which pay a fixed amount, 401 k s can rise and fall with...

Put away. What can be done to get americans to save more . Thats our cover story. Retirement in the u. S. Is becoming increasingly selffunded. In 197938 of private employers offer pension. Now its just 13 . The guaranteed retirement benefit is still common for government workers and union members, but private employers are more likely to offer 401 k s, employees put a portion of their pretax salary into taxdeferred accounts. Employers can match those contributions, although they dont have to. Unlike pensions which pay a fixed amount, 401 k s can rise and fall with the stock market. The Great R...

Longtime Fauquier resident Marion Poynter died on April 3. During her 97 years, she practiced journalism hands-on, fought to save it in a corporate struggle — and then, on more

The company is building what's being billed as one of the largest facilities of its kind in North America.

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs.When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing.